Companies Using Invoca

I've spent more than ten years building web crawling and technographic systems, and Invoca is the clearest example I've seen of a dataset that contradicts itself until you work out why. This analysis draws on our July 2026 crawl, which found Invoca on 23,779 active domains and matched 15,734 of them to enriched company records, a 66.2% match rate. The contradiction is worth stating up front: Invoca sells to enterprises, and 92.2% of the companies we detect it on have fewer than 50 employees.

Growth trajectory

For its first decade Invoca barely moved in our data. It appeared in October 2012, reached 13 domains by January 2016, 120 by 2018 and 529 by 2022. Then it accelerated hard: 1,890 in January 2024, 8,735 by April 2025. That's 4.6x inside fifteen months, and it's the steepest sustained run in our Call Tracking category. It also sits entirely inside one measurement system, so unlike the 2025 to 2026 step in the chart, which is our own coverage widening, this one is real. What changed isn't visible in detection data alone, but the shape is familiar: slow enterprise land, then rapid expansion once large accounts start deploying downstream.

"Invoca spent ten years under 600 domains and then multiplied almost fivefold in fifteen months. That isn't a marketing campaign. That's a small number of very large customers switching on a rollout." - Mehmet Suleyman, CEO & Co-founder at TechnologyChecker

Sales Signal: The addressable base is expanding fast but through existing accounts, not new logos. If you sell against Invoca, the opportunity isn't the enterprise contract, it's the hundreds of small sites each rollout creates. Those end users didn't choose the tool.

Customer profile

Here's the contradiction in numbers. 65.53% of Invoca domains have ten or fewer employees and only 1.93% exceed 1,000 staff. Yet sorted by headcount, the top of our Invoca list is ADP, Verizon, T-Mobile, PNC Financial Services, Northwell Health, Sherwin-Williams, Farmers Insurance and Travelers. Both facts come from the same crawl. The resolution is deployment shape: a national brand signs one contract and the tag lands on an agent, franchise or location network, so a single enterprise buyer generates hundreds of micro-business detections. The tech stack confirms it, and I'll come back to that. These are also not young companies. Just 8.34% were founded in the 2020s while 9.36% predate 1960, which fits established insurance and legal practices rather than digital-native startups.

Sales Signal: Count contracts, not detections, when you size this account base. 23,779 domains probably represents a few hundred real buying decisions. Sell to the brand at the top of the network, because the agency at the bottom has no budget authority over the tag.

Industry and geographic concentration

Invoca is the most concentrated platform in our Call Tracking category on both axes. Insurance alone is 44.82% of the base. Add Law Practice (13.88%) and Legal Services (6.33%) and insurance plus legal reach 65%. For contrast, CallRail's largest vertical is construction at 12.31%. Geographically it's even tighter: the United States is 15,370 of 15,587 enriched companies with a country on file, 98.6%, with Canada at 137 and the UK at 36. This is a product built for one regulatory and telecom environment, sold into two verticals where an inbound call is worth enough to justify recording and scoring it.

Sales Signal: Vertical concentration this extreme cuts both ways. Anything you sell to US insurance agencies has a ready-made list here. Anything you sell outside insurance, legal or healthcare will not find Invoca a useful targeting filter, and outside the US it's useless entirely.

Migration patterns

Invoca loses more domains than any other vendor in our data. Since March 2026 our crawler has watched 74 domains move from Invoca to CallRail and 14 to Patient Prism, against only 19 arriving from CallRail. That's a 4:1 loss ratio on the busiest single corridor in the category. Notably, Invoca barely trades with CallTrackingMetrics at all, 4 domains each way, even though they sit next to each other on market share. Products that don't exchange customers aren't competitors; they're serving different buyers. The Patient Prism flow is smaller but sharper, a specialist taking healthcare accounts from a generalist.

"Invoca and CallTrackingMetrics sit at 19% and 14% share and swap four domains each way. That's not a rivalry. The real contest is Invoca against its own customers deciding they only needed attribution." - Mehmet Suleyman, CEO & Co-founder at TechnologyChecker

Sales Signal: Domains that left Invoca for CallRail have just made a downgrade-and-save decision, which means budget scrutiny is active and other line items are exposed. On the retention side, Invoca's defensible ground is healthcare and insurance depth, which is exactly where Patient Prism is picking it off.

Technology ecosystem

This is where the enterprise-rollout reading stops being a theory. Adobe Analytics runs on 65.9% of Invoca domains and Ensighten on 44.83%. On CallTrackingMetrics domains those same tools appear on 1.71% and 0.44%. Facebook Pixel reaches 85.36% and TikTok Pixel 47.83%. A three-person insurance agency does not license Adobe Analytics and Ensighten, and it certainly doesn't run TikTok Pixel on half of all such sites by coincidence. These are templated properties carrying a corporate tag bundle. Meanwhile Google Analytics at 80.38% sits below the category norm of roughly 95%, which is itself a tell that these sites weren't built by their operators.

Sales Signal: The Adobe and Ensighten overlap is the cleanest enterprise filter in this category. Query Invoca plus Adobe Analytics on TechnologyChecker.io and you have a list of national brands running agent networks, rather than the agents themselves.

What the public record adds

Invoca's public positioning and our crawl describe the same company from opposite ends. The vendor markets AI conversation intelligence for enterprise revenue teams, and its named customers support that. Our data counts installations, so it reports the downstream footprint that "enterprise platform" hides. Neither view is wrong and each is incomplete alone. The practical consequence is that any category ranking by installed base will show Invoca as a small-business tool, and any ranking by contract value would show something else entirely. When comparing Invoca to Marchex or CallRail, be explicit about which of those two questions you're answering.

Sales Signal: Don't quote Invoca's 19.39% share as evidence of its size in a competitive deck without qualifying it. A buyer who knows the market will spot that 23,779 detections and a few hundred contracts are very different numbers, and the credibility cost isn't worth the point.

Key takeaways

1. Market position: #2 in Call Tracking at 19.39%, but competing for different contracts than the vendors ranked around it.
2. Growth phase: expanding fast, 4.6x between January 2024 and April 2025 in our detection history.
3. Core customer: a US insurance carrier or legal network deploying across many small agent sites.
4. Competitive moat: conversation intelligence depth plus an Adobe-grade enterprise integration surface no smaller rival matches.
5. Key vulnerability: a 4:1 net loss of domains to CallRail, the worst churn ratio in the category.
6. Concentration risk: 98.6% United States and 65% insurance plus legal, so two regulatory shocks reach almost the whole base.

Sales applications

Outreach angle: "You're running Invoca alongside Adobe Analytics and Ensighten, which tells us this is a managed rollout across your agent network rather than a single site. How are you reconciling call outcomes across those locations?"

Targeting strategy: on TechnologyChecker.io, filter Invoca detections to 1,000+ employees to isolate the roughly 300 enterprise parents, or filter to insurance under 10 employees to reach the agent layer. Those are two different campaigns and they should never share a message.

Competitive angle: the 74 domains that moved from Invoca to CallRail since March 2026 are in active cost review. The 14 that moved to Patient Prism are healthcare accounts that chose a specialist, which is the profile most open to vertical tooling.

Every figure above comes from our own crawl: 23,779 detected Invoca domains, 15,734 enriched company profiles, and observed switching across 29.9M active domains. Explore the full company list, filters and migration data at TechnologyChecker.io, or read our related analysis on GA4 migration and the sites that still haven't switched.